Chlamydia: Symptoms, Testing, Treatment, and Reinfection

What chlamydia is and how it spreads

Chlamydia is a sexually transmitted infection caused by the bacterium Chlamydia trachomatis. It is treatable and curable with prescribed antibiotics, but untreated infection can cause serious health problems. Many people have no symptoms, so feeling well does not rule out infection.

Chlamydia can spread through vaginal, anal, or oral sex with an infected partner. Transmission can occur even when the infected person has no noticeable symptoms. It can also pass from an infected pregnant person to a baby during childbirth. In newborns, infection can cause conjunctivitis or pneumonia.

Because symptoms may be absent or mild, testing is important when there has been a possible exposure, when symptoms develop, or when a sexual partner has been diagnosed. A diagnosis does not establish when the infection was acquired or prove that a partner was unfaithful. Symptoms can begin at variable times, and some people never notice symptoms at all.

Symptoms, discharge changes, and what appearance cannot tell you

Chlamydia symptoms depend partly on the infected site, and many infections cause none. Possible genital symptoms include discharge that differs from a person's usual pattern, bleeding between periods or after sex, burning when urinating, and lower abdominal pain. A person with a penis may notice white, cloudy, or watery discharge, along with possible testicular pain or swelling.

Rectal infection can cause pain, bleeding, or discharge. Infection involving the eye can cause redness, pain, or discharge. These symptoms are not specific to chlamydia, so they can have other causes.

Discharge color, thickness, smell, or amount cannot establish whether someone has chlamydia. The absence of discharge does not exclude it either. A laboratory test is needed to determine whether chlamydia is present. Appearance also cannot reliably identify the time of infection or the person who transmitted it.

Symptoms may start anywhere from one week to several months after infection, and many people remain symptom-free. That variability means symptom onset should not be used to date an exposure or decide whether testing is necessary. Genital ulcers, enlarged lymph nodes, or severe inflammation around the rectum are not typical uncomplicated chlamydia findings and may indicate a different condition, including a distinct infection caused by particular chlamydia strains.

When to seek testing and how chlamydia tests work

Contact a healthcare professional for testing if you have symptoms suggestive of chlamydia or if a sexual partner has been diagnosed. Do not wait for symptoms to become more obvious. When there are no symptoms, screening may still be appropriate based on age, anatomy, partners, and exposure. In the United States, CDC-based recommendations include annual screening for sexually active women younger than 25 and for older women with increased risk, such as a new partner, multiple partners, or a partner with an STI. Sexually active gay and bisexual men should be screened at least annually, with more frequent testing in higher-risk circumstances. The appropriate schedule can differ between individuals.

The recommended diagnostic method is a nucleic acid amplification test, or NAAT. It detects genetic material from chlamydia and is performed on a suitable urine or swab specimen. Under US guidance, vaginal swabs are optimal for women and first-catch urine is optimal for men. A swab collected by the patient in a clinical setting can perform comparably to one collected by a clinician.

The sample must match the site that may be infected. A genital urine sample or vaginal swab does not automatically check the rectum or every other exposed site. Rectal infection requires testing of a rectal specimen. Routine screening of the throat for chlamydia is not recommended by CDC guidance, although infection may be identified during combined testing.

Home collection kits may involve collecting urine or a swab and sending it to a laboratory. They can provide a way to collect a sample without an in-person appointment, but people with symptoms or a diagnosed partner should contact a healthcare professional rather than rely on a home kit alone or delay care. Test timing after a possible exposure can affect interpretation; discuss the timing and whether repeat testing is needed with the testing service instead of using symptom timing as a measure of test reliability.

Antibiotic treatment and why home remedies are not a cure

Chlamydia is treated with prescribed antibiotics. Supplements, douching, dietary changes, and nonprescription products are not substitutes for antibiotic treatment. A diagnosed infection should be treated rather than watched for symptoms to disappear, because symptoms may be absent or may improve without showing that the infection has been cleared.

For uncomplicated chlamydia in adolescents and adults, US CDC guidance recommends doxycycline 100 mg by mouth twice daily for seven days. The recommended pregnancy regimen is azithromycin 1 gram by mouth once. These are reference regimens, not instructions to self-prescribe. Treatment selection belongs to a healthcare professional, and these uncomplicated-infection regimens do not cover every situation, such as pelvic inflammatory disease, lymphogranuloma venereum, or newborn infection.

Treatment does not always require an in-person appointment. Depending on the service, a person may collect a urine or swab sample at home and receive care through an appropriate healthcare professional. Avoiding an office visit is different from treating chlamydia without prescribed antibiotics or professional involvement. Remote-care options and prescribing eligibility vary, so do not assume that every service can provide treatment without an evaluation.

Recovery, persistent symptoms, and when sex can resume

Several milestones are different: taking the prescribed treatment correctly, having symptoms improve, completing the period of sexual abstinence, and receiving later follow-up testing. One milestone does not automatically replace another.

Under US CDC guidance, people treated with a single-dose regimen should avoid sexual intercourse for seven days after treatment. People taking a seven-day regimen should wait until the regimen is complete and symptoms have resolved. In either situation, sexual partners also need to have been treated before sex resumes. Using condoms does not replace this treatment-related abstinence interval.

There is no single symptom-resolution day that applies to everyone. If symptoms persist, return, or worsen after treatment, contact a healthcare professional for reassessment. Persistent symptoms do not mean that choosing another antibiotic independently is appropriate. The clinician may need to consider reinfection, adherence, another infection, or another cause of the symptoms.

A routine test of cure is generally not advised for nonpregnant people who have completed a recommended or alternative regimen, unless adherence is uncertain, symptoms continue, or reinfection is suspected. A NAAT performed less than four weeks after treatment can be falsely positive because nonviable organisms may still be detected. Follow-up testing for reinfection is a separate step and is recommended approximately three months after treatment.

Partner treatment, follow-up tests, and preventing reinfection

Partners need care because an untreated partner can transmit chlamydia back after treatment. Under US guidance, sex partners during the 60 days before symptom onset or diagnosis should be referred for evaluation, testing, and presumptive treatment. The most recent partner should be evaluated and treated even if the last sexual contact occurred more than 60 days earlier.

A healthcare service can help with partner notification. The exact process varies, but the goal is to ensure that relevant partners receive information, evaluation, and treatment without relying on the treated person to manage all clinical decisions alone.

A test of cure asks whether infection is still detected after treatment. It is not routinely needed for nonpregnant people who completed treatment as recommended, unless there is a specific concern such as persistent symptoms, uncertain adherence, or suspected reinfection. In pregnancy, CDC guidance recommends a test of cure approximately four weeks after treatment, followed by retesting at approximately three months.

The approximately three-month retest is different: it looks for reinfection, which is common after treatment. It should not be confused with the pregnancy test of cure. Testing too early with NAAT can produce a positive result from nonviable organisms rather than ongoing infection. Most post-treatment infections reflect reinfection from an untreated or newly infected partner rather than treatment failure, although an individual result cannot be explained with certainty without clinical evaluation.

Complications, fertility, and chlamydia in pregnancy

Untreated chlamydia can spread upward from the cervix and contribute to pelvic inflammatory disease, or PID. PID may damage the fallopian tubes and can lead to infertility or ectopic pregnancy. These are possible complications, not inevitable outcomes of every infection. Treating infection promptly helps address the infection, but antibiotics should not be presented as reversing reproductive damage that has already occurred.

In people with testicles, chlamydia can cause epididymitis or epididymo-orchitis. Resulting male infertility is rare, but these complications require professional assessment. Lower abdominal pain, testicular pain or swelling, or other significant symptoms should not be managed by waiting for symptoms to disappear.

Pregnancy changes treatment and follow-up. Tell the treating professional about pregnancy or a possible pregnancy so the regimen can be selected appropriately. US guidance recommends a separate pregnancy regimen and a test of cure approximately four weeks after treatment, followed by retesting at approximately three months. A pregnant person should not apply a nonpregnancy regimen independently.

Chlamydia can pass to a baby during childbirth. Newborn infection may cause conjunctivitis or pneumonia. This is one reason diagnosis and treatment during pregnancy matter. A chlamydia diagnosis does not mean infertility is inevitable, and not every person with a past infection needs fertility testing. Concerns about fertility, pelvic pain, pregnancy, or prior PID should be discussed with a healthcare professional.

Reducing your risk of getting chlamydia again

Treatment prevents the current infection from continuing, but it does not create lasting immunity. A person can get chlamydia again after successful treatment, particularly if a partner was not treated or a new partner has the infection.

Risk-reduction steps include:

• Use condoms consistently during vaginal or anal sex.
• Use appropriate barriers during oral sex.
• Avoid sharing sex toys, or wash them and cover them with a new condom before another person uses them.
• Complete prescribed treatment as directed.
• Make sure relevant partners receive evaluation and treatment.
• Follow the recommended retesting plan, including the approximately three-month retest when advised.
• Seek testing when symptoms develop or a partner is diagnosed.

Screening schedules depend on anatomy, age, partners, exposure, and the guidance that applies where you live. Annual testing is recommended for some groups in the United States, but it is not a universal rule for every person. A healthcare professional or sexual-health service can help determine which sites to test and when.

Reducing transmission risk is not the same as guaranteeing protection. Barrier methods, appropriate testing, completed treatment, and partner care work together to lower the chance of acquiring or passing on chlamydia again.